loadpatents
Patent applications and USPTO patent grants for Heath; Julie Anne.The latest application filed is for "cycloalkyl substituted triazole compounds as agonists of the apj receptor".
Patent | Date |
---|---|
Heteroaryl-substituted triazoles as APJ receptor agonists Grant 11,046,680 - Chen , et al. June 29, 2 | 2021-06-29 |
Cycloalkyl substituted triazole compounds as agonists of the APJ receptor Grant 11,020,395 - Chen , et al. June 1, 2 | 2021-06-01 |
Triazole phenyl compounds as agonists of the APJ receptor Grant 10,906,890 - Chen , et al. February 2, 2 | 2021-02-02 |
Triazole furan compounds as agonists of the APJ receptor Grant 10,736,883 - Brown , et al. A | 2020-08-11 |
Cycloalkyl Substituted Triazole Compounds As Agonists Of The Apj Receptor App 20190290648 - CHEN; Yinhong ;   et al. | 2019-09-26 |
Triazole Phenyl Compounds As Agonists Of The Apj Receptor App 20190284173 - CHEN; Ning ;   et al. | 2019-09-19 |
Triazole Furan Compounds As Agonists Of The Apj Receptor App 20190275008 - BROWN; Matthew ;   et al. | 2019-09-12 |
Bromotriazole intermediates Grant 10,344,016 - Dransfield , et al. July 9, 2 | 2019-07-09 |
Bromotriazole Intermediates App 20190100510 - Dransfield; Paul John ;   et al. | 2019-04-04 |
Triazole agonists of the APJ receptor Grant 10,221,162 - Chen , et al. | 2019-03-05 |
Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor Grant 10,150,760 - Chen , et al. Dec | 2018-12-11 |
Triazole Agonists Of The Apj Receptor App 20180319773 - CHEN; Ning ;   et al. | 2018-11-08 |
Methods of treating heart failure Grant 10,058,550 - Chen , et al. August 28, 2 | 2018-08-28 |
Compounds For Use In Preparing Heterocyclic Triazole Agonists Of The Apj Receptor App 20180222895 - Chen; Xiaoqi ;   et al. | 2018-08-09 |
Heterocyclic triazole compounds as agonists of the APJ receptor Grant 9,988,369 - Chen , et al. June 5, 2 | 2018-06-05 |
Triazole agonists of the APJ receptor Grant 9,868,721 - Chen , et al. January 16, 2 | 2018-01-16 |
Intermediates for preparing triazole agonists of the APJ receptor Grant 9,845,310 - Chen , et al. December 19, 2 | 2017-12-19 |
Heterocyclic Triazole Compounds As Agonists Of The Apj Receptor App 20170320860 - CHEN; Xiaoqi ;   et al. | 2017-11-09 |
Methods Of Treating Heart Failure App 20170281625 - Chen; Ning ;   et al. | 2017-10-05 |
Methods for preparing triazole agonists of the APJ receptor Grant 9,751,864 - Chen , et al. September 5, 2 | 2017-09-05 |
Triazole agonists of the APJ receptor Grant 9,745,286 - Chen , et al. August 29, 2 | 2017-08-29 |
Intermediates for preparing triazole agonists of the APJ receptor Grant 9,656,998 - Chen , et al. May 23, 2 | 2017-05-23 |
Triazole agonists of the APJ receptor Grant 9,656,997 - Chen , et al. May 23, 2 | 2017-05-23 |
Triazole agonists of the APJ receptor Grant 9,573,936 - Chen , et al. February 21, 2 | 2017-02-21 |
Triazole Agonists Of The Apj Receptor App 20170042871 - Chen; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170042897 - Chen; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170042872 - CHEN; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170044131 - CHEN; Ning ;   et al. | 2017-02-16 |
Triazole Agonists Of The Apj Receptor App 20170035744 - CHEN; Ning ;   et al. | 2017-02-09 |
Triazole Agonists Of The Apj Receptor App 20170037026 - CHEN; Ning ;   et al. | 2017-02-09 |
Triazole Agonists Of The Apj Receptor App 20160340336 - Chen; Ning ;   et al. | 2016-11-24 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20140011796 - BARTBERGER; Michael David ;   et al. | 2014-01-09 |
Piperidinone Derivatives As Mdm2 Inhibitors For The Treatment Of Cancer App 20110319378 - BARTBERGER; Michael David ;   et al. | 2011-12-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.